|
4,5-dibromorhodamine 123 |
|---|---|
| Trade Name | Theralux Irradiation Device |
| Orphan Indication | Chronic myeloid leukemia |
| USA Market Approval | USA |
| USA Designation Date | 2003-04-10 00:00:00 |
| Sponsor | Kiadis Pharma Canada, Inc.;2525 Marie-Curie, Saint-Laurent (Quebec) H4S 2E1; |
Related Access Program
Pusan National University Hospital – Chronic Myeloid Leukemia
University of California, San Francisco – Chronic Myeloid Leukemia
Emory University – Chronic Myeloid Leukemia
Pusan National University Hospital – Chronic myeloid leukemia
University of California, San Francisco – Chronic myeloid leukemia
Pfizer – Chronic myeloid leukemia
Emory University – Chronic myeloid leukemia
